Hindustantimes wants to start sending you push notifications. Click allow to subscribe

Gilead’s remdesivir slows progression of Covid-19 in monkeys: Study

Reuters | ByReuters| Posted by Susmita Pakrasi
Jun 09, 2020 03:43 PM IST

In the study, macaques that received remdesivir did not show signs of respiratory disease and had reduced damage to the lungs, according to the study authors.

Gilead Sciences Inc’s antiviral drug, remdesivir, prevented lung disease in macaques infected with the new coronavirus, a study published in medical journal Nature said on Tuesday.

In the study, macaques that received remdesivir did not show signs of respiratory disease and had reduced damage to the lungs, according to the study authors.

Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away! - Login Now!

Get Latest World News along with Latest News from India at Hindustan Times.
SHARE THIS ARTICLE ON
Start 14 Days Free Trial Subscribe Now
OPEN APP